Credit Suisse’s Elevance Health ELV Stock Holding History

Credit Suisse’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,700	Closed	-$1.72M	–	3823
2021 Q4	$1.72M	Sell	3,700 -18,500	-83%	-$7.78M	﹤0.01%	2904
2021 Q3	$8.28M	Sell	22,200 -700	-3%	-$266K	﹤0.01%	1671
2021 Q2	$8.74M	Buy	+22,900	New	+$8.75M	﹤0.01%	1651
2021 Q1	–	Sell	-30,600	Closed	-$9.82M	–	4357
2020 Q4	$9.82M	Sell	30,600 -7,700	-20%	-$2.36M	﹤0.01%	1597
2020 Q3	$10.3M	Buy	38,300 +28,300	+283%	+$7.61M	0.01%	1368
2020 Q2	$2.63M	Hold	10,000	–	–	﹤0.01%	2164
2020 Q1	$2.27M	Sell	10,000 -13,800	-58%	-$3.76M	﹤0.01%	2052
2019 Q4	$7.19M	Hold	23,800	–	–	0.01%	1622
2019 Q3	$5.71M	Hold	23,800	–	–	﹤0.01%	1654
2019 Q2	$6.72M	Buy	+23,800	New	+$6.5M	0.01%	1553
2019 Q1	–	Sell	-27,700	Closed	-$7.28M	–	4009
2018 Q4	$7.28M	Buy	27,700 +22,700	+454%	+$6.24M	0.01%	1349
2018 Q3	$1.37M	Hold	5,000	–	–	﹤0.01%	2629
2018 Q2	$1.19M	Sell	5,000 -31,900	-86%	-$7.39M	﹤0.01%	2880
2018 Q1	$8.11M	Buy	+36,900	New	+$8.67M	0.01%	1373

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse's ELV Position: Q1 2024 in Review

Credit Suisse reduced its Elevance Health (ELV) stake by 2.7% in Q1 2024, selling an estimated $5.84M and leaving 422,240 shares worth $219M. The position accounts for 0.21% of the portfolio, ranked #86.

Credit Suisse first reported a position in ELV in Q2 2013 and has held it in 43 quarters since. The position peaked at $255M in Q4 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Credit Suisse held 422,240 shares of Elevance Health worth $219M as of Q1 2024.
Credit Suisse sold 11,742 Elevance Health shares in Q1 2024, an estimated $5.84M.
Elevance Health made up 0.21% of Credit Suisse's portfolio in Q1 2024, its #86 holding.
Credit Suisse first reported a position in Elevance Health in Q2 2013 and has held it in 43 quarters since.
Credit Suisse's Elevance Health position peaked at $255M in Q4 2022.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.